Dilip S. Shanghvi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) and 31 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharma promoter Dilip S. Shanghvi has filed a disclosure with the stock exchange under Regulation 31(4) and 31(5) of the SEBI Substantial Acquisition of Shares and Takeovers Regulations, 2011. These regulations require promoters to inform the exchange whenever there is a change in the number of shares they have pledged (encumbered) as collateral. The disclosure signals that there has been some change in the promoter's pledged shareholding position, though the specific direction or magnitude of the change is not disclosed in the headline.
This is a routine regulatory compliance filing rather than a material event, so it is unlikely to have a direct impact on the stock price. Investors should look for the detailed disclosure to understand whether the promoter pledged additional shares or released/reduced existing pledges, as high promoter pledging can be a risk factor for shareholders.